(Hyoscine butylbromide)

We are proud to announce that we obtained the Certificate of Suitability (CEP) for Butylscopolamine released by EDQM.

This Certificate is recognized not only by all Member States of the European Pharmacopoeia Convention but also by other Countries and it leads to a much easier and simpler approval process compared to the active substance master file (ASMF) or European drug master file (EDMF).

Certificate of Suitability
No. R0-CEP 2017-296-REV 00

Discover here Linnea’s BUTYLSCOPOLAMINE (Hyoscine butylbromide).